News & Articles

License agreement expands the rights to use and sell CRISPR/Cas9 reagents and tools

The tests will specifically adjust for isatuximab-induced interference in complete response assessment of multiple myeloma patients

Commercial U.S. launch of this novel diagnostic tool to diagnose lower respiratory tract infections is expected in the first quarter of 2020

Partnership will center on Prescient Medicine's novel genetic testing technology designed to objectively assess an individual's risk of opioid addiction

Scientists aim to gain new insights into natural cell activity, accelerating drug development

Enhertu targets the changes in HER2 that help the cancer grow, divide and spread

The ImpactAir range are microbial air samplers intended for environmental monitoring

Charging and discharging energy storage devices in BINDER chambers

Olympus SLIDEVIEW™ VS200 slide scanner and Ultivue UltiMapper™ reagents meet the changing needs of the scientific community

SAIL conducts research into the use of AI in Sartorius platform solutions for the biopharmaceutical industry

ETH researchers are making chocolate shimmer with rainbow colors by imprinting a special structure on the surface to create the effect

The change of name is a contractual requirement of its divestment from TTP Group in 2018 with the backing of technology-focused investment firm Battery Ventures

The Bio-PAT network for SMEs and research institutions aims to establish cooperation to accelerate bio-processes technology development

New agreement allows Markes International Ltd to supply the novel sampling device worldwide for a wide range of applications